CNR Institutional Research Information System

CUSIMANO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.589
NA - Nord America 924
EU - Europa 569
SA - Sud America 295
AF - Africa 29
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.409
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 864
SG - Singapore 659
CN - Cina 389
BR - Brasile 238
IT - Italia 189
HK - Hong Kong 173
VN - Vietnam 141
NL - Olanda 107
FR - Francia 99
KR - Corea 59
JP - Giappone 48
GB - Regno Unito 47
IN - India 36
AR - Argentina 24
CA - Canada 24
DE - Germania 24
MX - Messico 21
FI - Finlandia 20
BD - Bangladesh 18
ES - Italia 16
ZA - Sudafrica 12
ID - Indonesia 11
PL - Polonia 10
EC - Ecuador 9
RU - Federazione Russa 9
JM - Giamaica 8
AT - Austria 7
CO - Colombia 7
IL - Israele 7
IQ - Iraq 7
KE - Kenya 6
SE - Svezia 6
TR - Turchia 6
LT - Lituania 5
UY - Uruguay 5
HU - Ungheria 4
PY - Paraguay 4
UA - Ucraina 4
VE - Venezuela 4
CY - Cipro 3
EG - Egitto 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
OM - Oman 2
PK - Pakistan 2
PS - Palestinian Territory 2
RE - Reunion 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MG - Madagascar 1
NO - Norvegia 1
NR - Nauru 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.409
Salva come PNG Salva come JPEG
Città #
Singapore 407
Santa Clara 308
Hong Kong 170
Hefei 138
San Jose 95
Beijing 88
Lauterbourg 69
Ho Chi Minh City 57
Seoul 57
Ashburn 51
Los Angeles 39
Tokyo 38
Dallas 34
Hanoi 28
New York 24
São Paulo 20
Buffalo 17
Naples 14
Palermo 13
Helsinki 12
Milan 12
Mumbai 12
Mexico City 11
Orem 10
Frankfurt am Main 9
Montreal 9
Toronto 9
Amsterdam 8
Council Bluffs 8
Denver 8
Bengaluru 7
Boardman 7
Brooklyn 7
Cagliari 7
Houston 7
Minamishinagawa 7
Portsmouth 7
Rio de Janeiro 7
Warsaw 7
Chennai 6
City of London 6
Kensington 6
Kingston 6
London 6
Vienna 6
Atlanta 5
Elk Grove Village 5
Johannesburg 5
Lappeenranta 5
Nairobi 5
Poplar 5
Potenza 5
Stockholm 5
Ankara 4
Brasília 4
Bắc Ninh 4
Casandrino 4
Chicago 4
Da Nang 4
Dhaka 4
Madrid 4
Marigliano 4
Messina 4
Montevideo 4
Newark 4
Ninh Bình 4
Nuremberg 4
Paris 4
Roubaix 4
Xiamen 4
Asunción 3
Belo Horizonte 3
Bogotá 3
Bologna 3
Bratislava 3
Budapest 3
Carapicuíba 3
Cotia 3
Düsseldorf 3
Goiânia 3
Guayaquil 3
Haiphong 3
Jakarta 3
Lima 3
Manaus 3
Manchester 3
Marseille 3
Munich 3
Padua 3
Phoenix 3
Riga 3
Salvador 3
Thái Bình 3
Thái Nguyên 3
Turku 3
Zhengzhou 3
Amman 2
Anápolis 2
Apodaca 2
Aracaju 2
Totale 2.068
Salva come PNG Salva come JPEG
Nome #
Isolation of extracellular vesicles from microalgae: Towards the production of sustainable and natural nanocarriers of bioactive compounds 132
Nanoalgosomes: Introducing extracellular vesicles produced by microalgae 130
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach 97
Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies 95
BubbleMumble Lab: un Mobile Serious Game per l'apprendimento dei concetti legati ai processi di estrazione e funzionalizzazione delle vescicole extracellulari 93
The Role of Metaphor in Serious Games Design: the BubbleMumble Case Study 88
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 84
BubbleMumble Kart: un Web Serious Game per l'apprendimento dei concetti di base legati alle vescicole extracellulari 84
New landscapes and horizons in hepatocellular carcinoma therapy. 83
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 76
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH 68
Post-translational lipidation in extracellular vesicles: chemical mechanisms, biological functions and applications 66
BubbleMumble: A Serious Game for the Dissemination of Scientific Results in Secondary Schools 66
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 64
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 61
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 61
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 57
In vitro and in vivo antitumor activity of the proteasome inhibitor MLN2238 in hepatocellular carcinoma cells 56
Antioxidant Bioprospecting in Microalgae: Characterisation of the Potential of Two Marine Heterokonts from Irish Waters 53
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells 53
Hepatocellular Carcinoma: A Difficult Cancer to Treat 52
GSK-3 in liver diseases: Friend or foe? 52
VES4US: Extracellular vesicles from a natural source for tailor-made nanomaterials 52
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment 50
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 47
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview 47
Emerging Use of Nanotechnology for the Treatment of Liver Diseases 45
Sialylation of host proteins as targetable risk factor for COVID-19 susceptibility and spreading: A hypothesis 45
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors 44
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 44
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 42
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 40
The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells 38
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 38
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. 36
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 35
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 34
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 32
From targets to targeted therapies in Hepatocellular carcinoma 32
Molecular mechanisms of sorafenib action in liver cancer cells. 32
Cyclooxygenases in cancer 32
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 32
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 31
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 31
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 30
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 29
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 29
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 29
Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) 28
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 28
Gene expression profiling of human liver cancer cells following celecoxib treatment. 28
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 28
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. 28
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 27
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 27
A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. 27
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 27
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. 27
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. 26
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 26
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 26
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 25
Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells. 25
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 25
An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ 25
Wnt5a inhibits beta-catenin signaling and proliferation in hepatocyte cultures: Implications in liver regeneration 24
Changes in desmosomal proteins during liver regeneration after mouse partial hepatectomy 24
Episodic Ataxia Type 1 mutation F184C alters Zn2+-induced modulation of the human potassium channel Kv1.4-Kv1.1/Kv{beta}1.1. 24
WNT5A Inhibits Hepatocyte Proliferation and Concludes ?-Catenin Signaling in Liver Regeneration 24
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 23
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 23
Inhibition of cell growth in human hepatocellular carcinoma cells by selective COX-2 inhibitors 23
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 23
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells 22
Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? 22
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 21
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 20
Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production 19
Non-canonical Wnt signaling during liver regeneration 17
Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels 17
Calixarene-Based Nanostructures for Delivering Coumarin 6 for Tumor-Cell Imaging and Photoinduced Toxicity 15
Totale 3.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.203
article - articoli 5.925
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 560
Totale 16.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 0 0 0 0 0 0 0 0 1 0 14 9
2024/20251.394 29 8 90 40 282 74 17 87 78 120 315 254
2025/20262.023 94 204 225 364 382 67 255 117 134 125 56 0
Totale 3.441